pTau231Biomarker2 papersHumans2LatestNov 2025: 0Dec 2025: 7Jan 2026: 6Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 1Oct 2026: 015bioRxivHumansPreprint·24 SepAssociation of object mnemonic discrimination deficit with age and AD biomarkers in older adultsBiomarkersJournal of Neurology, Neurosurgery, and PsychiatryHumans·24 AugPresymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timingAlzheimer's diseaseAAIC 2025 AbstractHumans·11 JanAssociations of Estradiol and APOE4 Genotype with Hippocampal Connectivity during Verbal Encoding in Postmenopausal WomenMechanismsAAIC 2025 AbstractHumans·9 JanAmyloid‐beta subspecies in individuals with Down Syndrome, sporadic Alzheimer's disease (sAD) and PS1 mutations ‐ comparison using IP‐Mass Spectrometry of plasmaBiomarkersAAIC 2025 AbstractHumans·8 JanExamination and Identification of distinct and shared proteomic profiles linked to Alzheimer's Disease biomarkers across multiple proteomic platformsBiomarkersAAIC 2025 AbstractHumans·8 JanMapping Plasma Biomarker Progression Against the Amyloid ClockBiomarkersAAIC 2025 AbstractHumans·8 JanPlasma biomarkers move at different rates across the Alzheimer's disease continuumBiomarkersAAIC 2025 AbstractHumans·8 JanAn integrated censored and uncensored (ICU) twin model for biomarker heritability estimationBiomarkersAAIC 2025 AbstractHumans·26 DecSildenafil is a candidate drug for Alzheimer’s disease: Mechanism‐of‐action observation in patient iPSC‐derived brain organoids and a 5xFAD mouse modelInterventionsAAIC 2025 AbstractHumans·25 DecPlasma pTau and GFAP are associated with subjective cognitive decline and memory concerns in the remote, digital Brain Health Registry cohortBiomarkers
bioRxivHumansPreprint·24 SepAssociation of object mnemonic discrimination deficit with age and AD biomarkers in older adultsBiomarkers
Journal of Neurology, Neurosurgery, and PsychiatryHumans·24 AugPresymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timingAlzheimer's disease
AAIC 2025 AbstractHumans·11 JanAssociations of Estradiol and APOE4 Genotype with Hippocampal Connectivity during Verbal Encoding in Postmenopausal WomenMechanisms
AAIC 2025 AbstractHumans·9 JanAmyloid‐beta subspecies in individuals with Down Syndrome, sporadic Alzheimer's disease (sAD) and PS1 mutations ‐ comparison using IP‐Mass Spectrometry of plasmaBiomarkers
AAIC 2025 AbstractHumans·8 JanExamination and Identification of distinct and shared proteomic profiles linked to Alzheimer's Disease biomarkers across multiple proteomic platformsBiomarkers
AAIC 2025 AbstractHumans·8 JanMapping Plasma Biomarker Progression Against the Amyloid ClockBiomarkers
AAIC 2025 AbstractHumans·8 JanPlasma biomarkers move at different rates across the Alzheimer's disease continuumBiomarkers
AAIC 2025 AbstractHumans·8 JanAn integrated censored and uncensored (ICU) twin model for biomarker heritability estimationBiomarkers
AAIC 2025 AbstractHumans·26 DecSildenafil is a candidate drug for Alzheimer’s disease: Mechanism‐of‐action observation in patient iPSC‐derived brain organoids and a 5xFAD mouse modelInterventions
AAIC 2025 AbstractHumans·25 DecPlasma pTau and GFAP are associated with subjective cognitive decline and memory concerns in the remote, digital Brain Health Registry cohortBiomarkers